Pseudomonas
Cystic Fibrosis Sinus Infections Involve Microbes With Shifting Evolution Patterns
While early-stage Pseudomonas aeruginosa sinus infections were marked by selection for aggregating forms of the bug, genetic drift and genome degradation arose later in infection.
Curetis Receives €350K German Government Grant to Develop Carbapenem Resistance Test
The project, coordinated by Jena University Hospital and expected to run for five years, aims to address resistance mechanisms in Gram-negative pathogens.
Signature Science Gets CDC Contract to Evaluate Molecular Microbial Detection Methods
Signature Science will assess the validity of metagenomic and metatranscriptomic analyses to detect the transmission of viable pathogens in healthcare settings.
IDbyDNA, Locus Biosciences Partner on CDx for CRISPR Antimicrobial
The next-generation sequencing test will be used to select patients for a clinical trial of Locus' Pseudomonas aeruginosa antimicrobial product.
Cepheid, MedImmune, COMBACTE Ink Bacterial Dx Collaboration
Cepheid will create Xpert cartridge tests to detect S. aureus and P. aeuginosa, to be used in clinical trials for biologics intended to prevent pneumonia.